BridgeBio Pharma CEO Neil Kumar disposes of USD 3.07 million in common shares - BBIO News | RalliesBridgeBio Pharma CEO Neil Kumar disposes of USD 3.07 million in common shares
B
BBIO• CEO and trust sell BridgeBio shares
- BridgeBio Pharma CEO Neil Kumar sold 34,980 common shares on Aug. 18 at weighted-average prices of $81.15 to $83.77.
- His directly held stake fell to 243,327 shares.
- A family irrevocable trust where Kumar is co-trustee sold 10,000 shares on Aug. 19 at weighted-average prices of $83.86 to $85.65.
- The trust’s holdings declined to 505,686 shares.
SPY
•
